Total Payments
$5.2M
2024 Payments
$359,061
Companies
20
Transactions
417
Payment Breakdown by Category
Consulting$4.3M (83.5%)
Research$757,309 (14.7%)
Royalty/License$43,511 (0.8%)
Other$27,690 (0.5%)
Travel$17,176 (0.3%)
Food & Beverage$6,479 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4.3M | 251 | 83.5% |
| Unspecified | $757,309 | 53 | 14.7% |
| Royalty or License | $43,511 | 3 | 0.8% |
| Travel and Lodging | $17,176 | 27 | 0.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $15,400 | 4 | 0.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,290 | 2 | 0.2% |
| Food and Beverage | $6,479 | 77 | 0.1% |
Payments by Type
General
$4.4M
364 transactions
Research
$757,309
34 transactions
Ownership
$0
19 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LENSAR, Inc. | $1.7M | 118 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $1.3M | 61 | $0 (2021) |
| Beaver-Visitec International, Inc. | $502,656 | 4 | $0 (2024) |
| Bausch Health US, LLC | $492,150 | 23 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $339,927 | 60 | $0 (2017) |
| Bausch & Lomb Americas Inc. | $309,437 | 35 | $0 (2024) |
| Alcon Research LLC | $286,255 | 56 | $0 (2020) |
| Rayner Intraocular Lenses Limited | $134,993 | 13 | $0 (2023) |
| Visant Medical, Inc. | $47,209 | 9 | $0 (2022) |
| Tarsus Pharmaceuticals, Inc. | $34,750 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $359,061 | 26 | Beaver-Visitec International, Inc. ($168,519) |
| 2023 | $587,661 | 39 | LENSAR, Inc. ($184,016) |
| 2022 | $314,029 | 30 | Bausch & Lomb Americas Inc. ($135,850) |
| 2021 | $545,575 | 26 | LENSAR, Inc. ($262,000) |
| 2020 | $900,540 | 41 | Bausch & Lomb, a division of Bausch Health US, LLC ($451,500) |
| 2019 | $732,684 | 49 | Bausch & Lomb, a division of Bausch Health US, LLC ($344,068) |
| 2018 | $923,236 | 74 | Bausch & Lomb, a division of Bausch Health US, LLC ($348,263) |
| 2017 | $792,103 | 132 | Valeant Pharmaceuticals North America LLC ($339,927) |
All Payment Transactions
417 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Beaver-Visitec International, Inc. | PODEYE TORIC IOL (Device) | Consulting Fee | Cash or cash equivalent | $168,518.91 | General |
| Category: Intraocular lens (IOL) | ||||||
| 11/22/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $13,875.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/22/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $9,875.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $9,750.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/21/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $4,625.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $25,500.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/15/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $24,500.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/12/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $21,375.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2024 | Bausch & Lomb Americas Inc. | — | Consulting Fee | Cash or cash equivalent | $3,400.00 | General |
| 10/17/2024 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $117.31 | General |
| 10/04/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $15,375.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/16/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/11/2024 | LENSAR, Inc. | LENSAR LASER SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $16,000.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/11/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 07/10/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,875.00 | General |
| 07/10/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,125.00 | General |
| 05/08/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,250.00 | General |
| 04/25/2024 | Bausch & Lomb Americas Inc. | — | Consulting Fee | Cash or cash equivalent | $1,275.00 | General |
| 04/11/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,625.00 | General |
| 03/13/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,625.00 | General |
| 03/05/2024 | Bausch & Lomb Americas Inc. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 02/14/2024 | Tarsus Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 2024 | Amaros, Inc. | — | — | — | $0.00 | Ownership |
| 2024 | Oculotix, Inc. | — | — | — | $0.00 | Ownership |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A STUDY TO DOCUMENT THE SAFETY AND EFFECTIVENESS OF A NEW OPHTHALMIC VISCOSURGICAL DEVICE OVD WHEN COMPARED TO A CONTROL OVD | Bausch Health US, LLC | $251,550 | 12 |
| A STUDY TO DOCUMENT THE SAFETY AND EFFECTIVENESS OF A NEW COHESIVE OVD WHEN COMPARED TO A CONTROL OVD | Bausch Health US, LLC | $196,350 | 8 |
| A Study to Document the Safety and Effectiveness of a New Ophthalmic Viscosurgical Device OVD When Compared to a Control OVD | Valeant Pharmaceuticals North America LLC | $101,059 | 10 |
| BAUSCH & LOMB OVD DISPERSIVE DVISC40 STUDY S877 | Bausch Health US, LLC | $44,250 | 3 |
About Dr. Mark Packer, M.D
Dr. Mark Packer, M.D is a Ophthalmology healthcare provider based in Boulder, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205834439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Packer, M.D has received a total of $5.2M in payments from pharmaceutical and medical device companies, with $359,061 received in 2024. These payments were reported across 417 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($4.3M).
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Ophthalmology
- Location Boulder, CO
- Active Since 07/12/2005
- Last Updated 12/20/2018
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1205834439
Products in Payments
- LENSAR LASER SYSTEM (Device) $1.7M
- TRULIGN TORIC (Device) $658,956
- ENVISTA (Device) $368,608
- LOTEMAX (Drug) $297,600
- PODEYE TORIC IOL (Device) $168,519
- CyPass (Device) $160,908
- DVISC40 (Device) $157,972
- CVISC50 (Device) $133,650
- Trulign IOL (Device) $84,600
- AcrySof (Device) $82,250
- OMIDRIA (Drug) $71,500
- BIOTRUE (Device) $33,600
- NGENUITY (Device) $25,240
- IC-8 Apthera IOL (Device) $14,295
- ORA (Device) $10,610
- CRYSTALENS (Device) $10,555
- ENVISTA TORIC (Device) $5,433
- miLOOP (Device) $4,290
- RAO600C (Device) $4,165
- CLEARVISC (Device) $2,900
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Boulder
Mrs. Geeta Lalchandani-Lalwani, M.d, M.D
Ophthalmology — Payments: $362,059
Ophthalmology $362,059
Dr. Brent Deibert, Md, MD
Ophthalmology — Payments: $8,438
Ophthalmology $8,438
Mr. Kevin Cuevas, Md, MD
Ophthalmology — Payments: $1,989
Ophthalmology $1,989
Ken Kreidl, M.d, M.D
Ophthalmology — Payments: $1,581
Ophthalmology $1,581
Donald Keller, Md, MD
Ophthalmology — Payments: $1,312
Ophthalmology $1,312
Dr. Niles Utlaut, Md, MD
Ophthalmology — Payments: $1,064
Ophthalmology $1,064